Roth Capital upgraded shares of Monogram Orthopaedics (NASDAQ:MGRM – Free Report) to a strong-buy rating in a research note issued to investors on Monday,Zacks.com reports.
Separately, Roth Mkm began coverage on shares of Monogram Orthopaedics in a report on Monday. They set a “buy” rating and a $4.00 price objective on the stock.
View Our Latest Report on MGRM
Monogram Orthopaedics Trading Up 9.3 %
Hedge Funds Weigh In On Monogram Orthopaedics
Several hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC increased its holdings in Monogram Orthopaedics by 1,267.4% in the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock worth $557,000 after buying an additional 194,776 shares during the period. State Street Corp acquired a new position in Monogram Orthopaedics during the third quarter valued at $62,000. Finally, Barclays PLC purchased a new stake in Monogram Orthopaedics in the third quarter valued at $29,000. 0.45% of the stock is owned by institutional investors and hedge funds.
Monogram Orthopaedics Company Profile
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Recommended Stories
- Five stocks we like better than Monogram Orthopaedics
- Conference Calls and Individual Investors
- Is Amplitude an AI Sleeper Stock in the Making for 2025?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Pure Storage Rides the AI Boom Even Higher in 2025
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- GXO Logistics: Time to Buy the Dip for the Rip in 2025
Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.